Literature DB >> 9362015

Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium on thallium reinjection imaging.

M Petretta1, A Cuocolo, D Bonaduce, E Nicolai, M L Vicario, M Salvatore.   

Abstract

BACKGROUND: We evaluated the independent and incremental prognostic value of cardiac catheterization and coronary angiographic data over thallium reinjection after stress redistribution imaging in patients with myocardial infarction and left ventricular dysfunction. METHODS AND
RESULTS: Sixty-nine patients with a first myocardial infarction (> 8 weeks) and left ventricular ejection fraction < or = 40% underwent thallium-201 reinjection after stress redistribution tomographic imaging and cardiac catheterization. During follow-up (mean 26 months) 11 cardiac events (8 cardiac deaths and 3 nonfatal myocardial infarctions) occurred. On Cox regression analysis independent predictors of cardiac events were the sum of reversible and moderately irreversible defects at thallium reinjection (chi 2, 16.4, p < 0.005) and the number of reversible defects at stress redistribution (chi 2, 5.1, p < 0.05). Moreover, thallium reinjection imaging improved the prognostic power of clinical, exercise, and stress redistribution data (p < 0.01). The inclusion of left ventricular ejection fraction produced a borderline improvement (p = 0.06), whereas the number of vessels with coronary disease did not. In contrast, in patients at high risk such as those with at least 25% of viable myocardium at reinjection, the number of diseased vessels provided additional prognostic information (p < 0.05).
CONCLUSIONS: In patients with chronic ischemic left ventricular dysfunction, left ventricular ejection fraction, but not the number of diseased vessels, provides additional prognostic information to thallium imaging. Therefore coronary angiography seems unnecessary in these patients, unless a significative amount of viable myocardium is detectable.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362015     DOI: 10.1016/s1071-3581(97)90030-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  28 in total

1.  Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests.

Authors:  S G Pollock; R D Abbott; C A Boucher; G A Beller; S Kaul
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

2.  A decision scheme for coronary angiography after acute myocardial infarction.

Authors:  J Ross; E A Gilpin; E B Madsen; H Henning; P Nicod; H Dittrich; R Engler; J Rittelmeyer; S C Smith; C Viquerat
Journal:  Circulation       Date:  1989-02       Impact factor: 29.690

3.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man.

Authors:  H Sandler; H T Dodge
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

4.  Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data.

Authors:  P Y Marie; N Danchin; J F Durand; L Feldmann; A Grentzinger; P Olivier; G Karcher; Y Juillière; J M Virion; D Beurrier
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

5.  Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease.

Authors:  S Maurea; A Cuocolo; A Soricelli; L Castelli; A Nappi; F Squame; M Imbriaco; B Trimarco; M Salvatore
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

6.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

7.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

8.  Prognostic value of a coronary artery jeopardy score.

Authors:  R M Califf; H R Phillips; M C Hindman; D B Mark; K L Lee; V S Behar; R A Johnson; D B Pryor; R A Rosati; G S Wagner
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

9.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

10.  Risk stratification in survivors of acute myocardial infarction: routine cardiac catheterization and angiography is a reasonable approach in most patients.

Authors:  D L Kulick; S H Rahimtoola
Journal:  Am Heart J       Date:  1991-02       Impact factor: 4.749

View more
  4 in total

1.  Extent of myocardial viability in regions of left ventricular dysfunction by rest-redistribution thallium-201 imaging: a powerful predictor of outcome.

Authors:  G A Beller; M Ragosta
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

2.  Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?

Authors:  Z X He; M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

3.  The VANQWISH Trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction.

Authors:  G A Beller; K A Brown
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

4.  Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  M Petretta; A Cuocolo; E Nicolai; W Acampa; M Salvatore; D Bonaduce
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.